Characterization of platelet-monocyte complexes in HIV-1-infected individuals: Possible role in HIV-associated neuroinflammation

Journal of Immunology

Volumn 192, Issue 10, 2014, Pages 4674-4684

  Singh, Meera V ^a   Davidson, Donna C ^a   Jackson, Joseph W ^a   Singh, Vir B ^a   Silva, Jharon ^a   Ramirez, Servio H ^b   Maggirwar, Sanjay B ^a  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^b TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA3 INTEGRIN; CD40 LIGAND; P SELECTIN GLYCOPROTEIN LIGAND 1;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL INTERACTION; COMPLEX FORMATION; CONTROLLED STUDY; ENCEPHALITIS; FEMALE; FLOW CYTOMETRY; HIV 1 ASSOCIATED ENCEPHALITIS; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MEMBRANE PERMEABILITY; MICROVASCULAR ENDOTHELIAL CELL; MONOCYTE; MOUSE; NONHUMAN; PRIORITY JOURNAL; THROMBOCYTE; THROMBOCYTE ACTIVATION; TRANSENDOTHELIAL AND TRANSEPITHELIAL MIGRATION;

ADULT; BLOOD PLATELETS; BLOOD-BRAIN BARRIER; CD40 LIGAND; CEREBROVASCULAR CIRCULATION; ENCEPHALITIS; ENDOTHELIAL CELLS; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; INTEGRIN BETA3; MALE; MIDDLE AGED; MONOCYTES;

EID: 84901277222     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1302318     Document Type: Article

References (51)

1. Davis, L. E., B. L. Hjelle, V. E. Miller, D. L. Palmer, A. L. Llewellyn, T. L. Merlin, S. A. Young, R. G. Mills, W. Wachsman, and C. A. Wiley. 1992. Early viral brain invasion in iatrogenic human immunodeficiency virus infection. Neurology 42: 1736-1739.
2. Alexaki, A., Y. Liu, and B. Wigdahl. 2008. Cellular reservoirs of HIV-1 and their role in viral persistence. Curr. HIV Res. 6: 388-400.
3. Petito, C. K., E. S. Cho, W. Lemann, B. A. Navia, and R. W. Price. 1986. Neuropathology of acquired immunodeficiency syndrome (AIDS): an autopsy review. J. Neuropathol. Exp. Neurol. 45: 635-646.
4. Heaton, R. K., D. B. Clifford, D. R. Franklin, Jr., S. P. Woods, C. Ake, F. Vaida, R. J. Ellis, S. L. Letendre, T. D. Marcotte, J. H. Atkinson, et al; CHARTER Group. 2010. HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy: CHARTER Study. Neurology 75: 2087-2096.
5. Bezzi, P., M. Domercq, L. Brambilla, R. Galli, D. Schols, E. De Clercq, A. Vescovi, G. Bagetta, G. Kollias, J. Meldolesi, and A. Volterra. 2001. CXCR4- activated astrocyte glutamate release via TNFa: amplification by microglia triggers neurotoxicity. Nat. Neurosci. 4: 702-710.
6. Kaul, M., and S. A. Lipton. 1999. Chemokines and activated macrophages in HIV gp120-induced neuronal apoptosis. Proc. Natl. Acad. Sci. USA 96: 8212-8216.
7. Glass, J. D., H. Fedor, S. L. Wesselingh, and J. C. McArthur. 1995. Immunocytochemical quantitation of human immunodeficiency virus in the brain: correlations with dementia. Ann. Neurol. 38: 755-762.
8. Kaul, M., J. Zheng, S. Okamoto, H. E. Gendelman, and S. A. Lipton. 2005. HIV- 1 infection and AIDS: consequences for the central nervous system. Cell Death Differ. 12(Suppl. 1): 878-892.
9. Strauss-Ayali, D., S. M. Conrad, and D. M. Mosser. 2007. Monocyte subpopulations and their differentiation patterns during infection. J. Leukoc. Biol. 82: 244-252.
10. Thieblemont, N., L. Weiss, H. M. Sadeghi, C. Estcourt, and N. Haeffner-Cavaillon. 1995. CD14lowCD16high: a cytokine-producing monocyte subset which expands during human immunodeficiency virus infection. Eur. J. Immunol. 25: 3418-3424.
11. Ellery, P. J., E. Tippett, Y. L. Chiu, G. Paukovics, P. U. Cameron, A. Solomon, S. R. Lewin, P. R. Gorry, A. Jaworowski, W. C. Greene, et al. 2007. The CD16+ monocyte subset is more permissive to infection and preferentially harbors HIV- 1 in vivo. J. Immunol. 178: 6581-6589.
12. Fischer-Smith, T., C. Bell, S. Croul, M. Lewis, and J. Rappaport. 2008. Monocyte/macrophage trafficking in acquired immunodeficiency syndrome encephalitis: lessons from human and nonhuman primate studies. J. Neurovirol. 14: 318-326.
13. Fischer-Smith, T., S. Croul, A. E. Sverstiuk, C. Capini, D. L'Heureux, E. G. Régulier, M. W. Richardson, S. Amini, S. Morgello, K. Khalili, and J. Rappaport. 2001. CNS invasion by CD14+/CD16+ peripheral blood-derived monocytes in HIV dementia: perivascular accumulation and reservoir of HIV infection. J. Neurovirol. 7: 528-541.
14. Pulliam, L., R. Gascon, M. Stubblebine, D. McGuire, and M. S. McGrath. 1997. Unique monocyte subset in patients with AIDS dementia. Lancet 349: 692-695.
15. da Costa Martins, P. A., J. M. van Gils, A. Mol, P. L. Hordijk, and J. J. Zwaginga. 2006. Platelet binding to monocytes increases the adhesive properties of monocytes by up-regulating the expression and functionality of b1 and b2 integrins. J. Leukoc. Biol. 79: 499-507.
16. Ancuta, P., R. Rao, A. Moses, A. Mehle, S. K. Shaw, F. W. Luscinskas, and D. Gabuzda. 2003. Fractalkine preferentially mediates arrest and migration of CD16+ monocytes. J. Exp. Med. 197: 1701-1707.
17. van Gils, J. M., J. J. Zwaginga, and P. L. Hordijk. 2009. Molecular and functional interactions among monocytes, platelets, and endothelial cells and their relevance for cardiovascular diseases. J. Leukoc. Biol. 85: 195-204.
18. Elalamy, I., T. Chakroun, G. T. Gerotziafas, A. Petropoulou, F. Robert, A. Karroum, F. Elgrably, M. M. Samama, and M. Hatmi. 2008. Circulating platelet-leukocyte aggregates: a marker of microvascular injury in diabetic patients. Thromb. Res. 121: 843-848.
19. Furman, M. I., M. R. Barnard, L. A. Krueger, M. L. Fox, E. A. Shilale, D. M. Lessard, P. Marchese, A. L. Frelinger, III, R. J. Goldberg, and A. D. Michelson. 2001. Circulating monocyte-platelet aggregates are an early marker of acute myocardial infarction. J. Am. Coll. Cardiol. 38: 1002-1006.
20. Rinder, H. M., J. L. Bonan, C. S. Rinder, K. A. Ault, and B. R. Smith. 1991. Dynamics of leukocyte-platelet adhesion in whole blood. Blood 78: 1730-1737.
21. Singh, M. V., D. C. Davidson, M. Kiebala, and S. B. Maggirwar. 2012. Detection of circulating platelet-monocyte complexes in persons infected with human immunodeficiency virus type-1. J. Virol. Methods 181: 170-176.
22. Li, N., H. Hu, M. Lindqvist, E. Wikströlm-Jonsson, A. H. Goodall, and P. Hjemdahl. 2000. Platelet-leukocyte cross talk in whole blood. Arterioscler. Thromb. Vasc. Biol. 20: 2702-2708.
23. Holme, P. A., F. Muller, N. O. Solum, F. Brosstad, S. S. Frøland, and P. Aukrust. 1998. Enhanced activation of platelets with abnormal release of RANTES in human immunodeficiency virus type 1 infection. FASEB J. 12: 79-89.
24. Sui, Z., L. F. Sniderhan, G. Schifitto, R. P. Phipps, H. A. Gelbard, S. Dewhurst, and S. B. Maggirwar. 2007. Functional synergy between CD40 ligand and HIV-1 Tat contributes to inflammation: implications in HIV type 1 dementia. J. Immunol. 178: 3226-3236.
25. André, P., L. Nannizzi-Alaimo, S. K. Prasad, and D. R. Phillips. 2002. Plateletderived CD40L: the switch-hitting player of cardiovascular disease. Circulation 106: 896-899.
26. Davidson, D. C., M. P. Hirschman, A. Sun, M. V. Singh, K. Kasischke, and S. B. Maggirwar. 2012. Excess soluble CD40L contributes to blood brain barrier permeability in vivo: implications for HIV-associated neurocognitive disorders. PLoS ONE 7: e51793.
27. Ramirez, S. H., D. Heilman, B. Morsey, R. Potula, J. Haorah, and Y. Persidsky. 2008. Activation of peroxisome proliferator-activated receptor g (PPARg) suppresses Rho GTPases in human brain microvascular endothelial cells and inhibits adhesion and transendothelial migration of HIV-1 infected monocytes. J. Immunol. 180: 1854-1865.
28. Ramirez, S. H., S. Fan, H. Dykstra, N. Reichenbach, L. Del Valle, R. Potula, R. P. Phipps, S. B. Maggirwar, and Y. Persidsky. 2010. Dyad of CD40/CD40 ligand fosters neuroinflammation at the blood-brain barrier and is regulated via JNK signaling: implications for HIV-1 encephalitis. J. Neurosci. 30: 9454-9464.
29. Weerasinghe, D., K. P. McHugh, F. P. Ross, E. J. Brown, R. H. Gisler, and B. A. Imhof. 1998. A role for the avb3 integrin in the transmigration of monocytes. J. Cell Biol. 142: 595-607.
30. Lafrenie, R. M., S. F. Lee, I. K. Hewlett, K. M. Yamada, and S. Dhawan. 2002. Involvement of integrin avb3 in the pathogenesis of human immunodeficiency virus type 1 infection in monocytes. Virology 297: 31-38.
31. Rank, A., R. Nieuwland, R. Delker, V. Pihusch, R. Wilkowski, B. Toth, H. J. Kolb, and R. Pihusch. 2011. Surveillance of megakaryocytic function by measurement of CD61-exposing microparticles in allogeneic hematopoietic stem cell recipients. Clin. Transplant. 25: E233-E242.
32. George, J. N., L. L. Thoi, L. M. McManus, and T. A. Reimann. 1982. Isolation of human platelet membrane microparticles from plasma and serum. Blood 60: 834-840.
33. Heijnen, H. F., A. E. Schiel, R. Fijnheer, H. J. Geuze, and J. J. Sixma. 1999. Activated platelets release two types of membrane vesicles: microvesicles by surface shedding and exosomes derived from exocytosis of multivesicular bodies and a-granules. Blood 94: 3791-3799.
34. Ramirez, S. H., N. L. Reichenbach, S. Fan, S. Rom, S. F. Merkel, X. Wang, W. Z. Ho, and Y. Persidsky. 2013. Attenuation of HIV-1 replication in macrophages by cannabinoid receptor 2 agonists. J. Leukoc. Biol. 93: 801-810.
35. McArthur, J. C., J. Steiner, N. Sacktor, and A. Nath. 2010. Human immunodeficiency virus-associated neurocognitive disorders: mind the gap. Ann. Neurol. 67: 699-714.
36. Davidson, D. C., M. P. Hirschman, S. L. Spinelli, C. N. Morrell, G. Schifitto, R. P. Phipps, and S. B. Maggirwar. 2011. Antiplatelet activity of valproic acid contributes to decreased soluble CD40 ligand production in HIV type 1-infected individuals. J. Immunol. 186: 584-591.
37. Davidson, D. C., G. Schifitto, and S. B. Maggirwar. 2013. Valproic acid inhibits the release of soluble CD40L induced by non-nucleoside reverse transcriptase inhibitors in human immunodeficiency virus infected individuals. PLoS ONE 8: e59950.
38. Yago, T., M. Tsukuda, and M. Minami. 1999. P-selectin binding promotes the adhesion of monocytes to VCAM-1 under flow conditions. J. Immunol. 163: 367-373.
39. da Costa Martins, P., N. van den Berk, L. H. Ulfman, L. Koenderman, P. L. Hordijk, and J. J. Zwaginga. 2004. Platelet-monocyte complexes support monocyte adhesion to endothelium by enhancing secondary tethering and cluster formation. Arterioscler. Thromb. Vasc. Biol. 24: 193-199.
40. Theilmeier, G., T. Lenaerts, C. Remacle, D. Collen, J. Vermylen, and M. F. Hoylaerts. 1999. Circulating activated platelets assist THP-1 monocytoid/ endothelial cell interaction under shear stress. Blood 94: 2725-2734.
41. O'Brien, M., E. Montenont, L. Hu, M. A. Nardi, V. Valdes, M. Merolla, G. Gettenberg, K. Cavanagh, J. A. Aberg, N. Bhardwaj, and J. S. Berger. 2013. Aspirin attenuates platelet activation and immune activation in HIV-1-infected subjects on antiretroviral therapy: a pilot study. J. Acquir. Immune Defic. Syndr. 63: 280-288.
42. Gremmel, T., R. B. Eslam, R. Koppensteiner, I. M. Lang, and S. Panzer. 2013. Prasugrel reduces agonists' inducible platelet activation and leukocyte-platelet interaction more efficiently than clopidogrel. Cardiovasc. Ther. 31: e40-e45.
43. Schifitto, G., D. R. Peterson, J. Zhong, H. Ni, K. Cruttenden, M. Gaugh, H. E. Gendelman, M. Boska, and H. Gelbard. 2006. Valproic acid adjunctive therapy for HIV-associated cognitive impairment: a first report. Neurology 66: 919-921.
44. Islam, F. M., J. Wu, J. Jansson, and D. P. Wilson. 2012. Relative risk of cardiovascular disease among people living with HIV: a systematic review and meta-analysis. HIV Med. 13: 453-468.
45. Palella, F. J., Jr., and J. P. Phair. 2011. Cardiovascular disease in HIV infection. Curr. Opin. HIV AIDS 6: 266-271.
46. Ingersoll, M. A., R. Spanbroek, C. Lottaz, E. L. Gautier, M. Frankenberger, R. Hoffmann, R. Lang, M. Haniffa, M. Collin, F. Tacke, et al. 2010. Comparison of gene expression profiles between human and mouse monocyte subsets. Blood 115: e10-e19.
47. Schulz, C., M. L. von Bruhl, V. Barocke, P. Cullen, K. Mayer, R. Okrojek, A. Steinhart, Z. Ahmad, E. Kremmer, B. Nieswandt, et al. 2011. EMMPRIN (CD147/basigin) mediates platelet-monocyte interactions in vivo and augments monocyte recruitment to the vascular wall. J. Thromb. Haemost. 9: 1007-1019.
48. Postea, O., E. M. Vasina, S. Cauwenberghs, D. Projahn, E. A. Liehn, D. Lievens, W. Theelen, B. K. Kramp, E. D. Butoi, O. Soehnlein, et al. 2012. Contribution of platelet CX(3)CR1 to platelet-monocyte complex formation and vascular recruitment during hyperlipidemia. Arterioscler. Thromb. Vasc. Biol. 32: 1186-1193.
49. Laidlaw, T. M., M. S. Kidder, N. Bhattacharyya, W. Xing, S. Shen, G. L. Milne, M. C. Castells, H. Chhay, and J. A. Boyce. 2012. Cysteinyl leukotriene overproduction in aspirin-exacerbated respiratory disease is driven by plateletadherent leukocytes. Blood 119: 3790-3798.
50. Pitchford, S. C., S. Momi, S. Baglioni, L. Casali, S. Giannini, R. Rossi, C. P. Page, and P. Gresele. 2008. Allergen induces the migration of platelets to lung tissue in allergic asthma. Am. J. Respir. Crit. Care Med. 177: 604-612.
51. van Gils, J. M., P. A. da Costa Martins, A. Mol, P. L. Hordijk, and J. J. Zwaginga. 2008. Transendothelial migration drives dissociation of plateletmonocyte complexes. Thromb. Haemost. 100: 271-279.